Giulio Preta

965 total citations
21 papers, 704 citations indexed

About

Giulio Preta is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Giulio Preta has authored 21 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Giulio Preta's work include Lipid Membrane Structure and Behavior (6 papers), RNA Interference and Gene Delivery (4 papers) and Ubiquitin and proteasome pathways (4 papers). Giulio Preta is often cited by papers focused on Lipid Membrane Structure and Behavior (6 papers), RNA Interference and Gene Delivery (4 papers) and Ubiquitin and proteasome pathways (4 papers). Giulio Preta collaborates with scholars based in Lithuania, Sweden and United Kingdom. Giulio Preta's co-authors include I. Martin Sheldon, J. Cronin, Ana L. Santos, Bengt Fadeel, Sholeem Griffin, Rickard Glas, Virginia Lotti, Gintaras Valinčius, Marija Jankunec and Frank Heinrich and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Giulio Preta

19 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulio Preta Lithuania 13 471 106 81 69 63 21 704
Catalina Ana Rosselló Spain 12 616 1.3× 162 1.5× 64 0.8× 69 1.0× 39 0.6× 16 884
Daphne M. van Elsland Netherlands 11 297 0.6× 135 1.3× 40 0.5× 40 0.6× 47 0.7× 16 563
Xiangxiang Zhang China 17 511 1.1× 99 0.9× 59 0.7× 171 2.5× 103 1.6× 56 1.0k
Naveid Ali Australia 10 665 1.4× 127 1.2× 121 1.5× 84 1.2× 54 0.9× 13 1.0k
Anne-Marie Hesse France 16 710 1.5× 79 0.7× 82 1.0× 83 1.2× 32 0.5× 34 1.0k
Katarzyna M. Kedziora United States 18 568 1.2× 187 1.8× 45 0.6× 61 0.9× 63 1.0× 43 905
Giovanni Smaldone Italy 17 606 1.3× 43 0.4× 59 0.7× 79 1.1× 64 1.0× 71 907
Amy Schutz‐Geschwender United States 13 587 1.2× 120 1.1× 57 0.7× 65 0.9× 188 3.0× 15 943
Benjamin Bruno United States 12 560 1.2× 62 0.6× 68 0.8× 26 0.4× 96 1.5× 24 1.1k
Mohamed Kodiha Canada 20 883 1.9× 145 1.4× 69 0.9× 58 0.8× 157 2.5× 42 1.2k

Countries citing papers authored by Giulio Preta

Since Specialization
Citations

This map shows the geographic impact of Giulio Preta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulio Preta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulio Preta more than expected).

Fields of papers citing papers by Giulio Preta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulio Preta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulio Preta. The network helps show where Giulio Preta may publish in the future.

Co-authorship network of co-authors of Giulio Preta

This figure shows the co-authorship network connecting the top 25 collaborators of Giulio Preta. A scholar is included among the top collaborators of Giulio Preta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulio Preta. Giulio Preta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Preta, Giulio, et al.. (2024). Effect of Statin Lipophilicity on the Proliferation of Hepatocellular Carcinoma Cells. Biology. 13(6). 455–455.
2.
Preta, Giulio. (2023). Development of New Genome Editing Tools for the Treatment of Hyperlipidemia. Cells. 12(20). 2466–2466. 8 indexed citations
3.
Preta, Giulio, et al.. (2022). Membrane Cholesterol Content and Lipid Organization Influence Melittin and Pneumolysin Pore-Forming Activity. Toxins. 14(5). 346–346. 6 indexed citations
4.
Preta, Giulio. (2020). New Insights Into Targeting Membrane Lipids for Cancer Therapy. Frontiers in Cell and Developmental Biology. 8. 571237–571237. 90 indexed citations
5.
Valinčius, Gintaras, et al.. (2020). Pleiotropic effects of statins via interaction with the lipid bilayer: A combined approach. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1862(9). 183306–183306. 27 indexed citations
6.
Preta, Giulio, et al.. (2018). Biological applications of tethered bilayer lipid membranes. Biochimie. 157. 131–141. 25 indexed citations
7.
Santos, Ana L. & Giulio Preta. (2018). Lipids in the cell: organisation regulates function. Cellular and Molecular Life Sciences. 75(11). 1909–1927. 112 indexed citations
8.
Griffin, Sholeem, Giulio Preta, & I. Martin Sheldon. (2017). Inhibiting mevalonate pathway enzymes increases stromal cell resilience to a cholesterol-dependent cytolysin. Scientific Reports. 7(1). 17050–17050. 26 indexed citations
9.
Preta, Giulio, Marija Jankunec, Frank Heinrich, et al.. (2016). Tethered bilayer membranes as a complementary tool for functional and structural studies: The pyolysin case. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1858(9). 2070–2080. 27 indexed citations
10.
Preta, Giulio, J. Cronin, & I. Martin Sheldon. (2015). Dynasore - not just a dynamin inhibitor. Cell Communication and Signaling. 13(1). 24–24. 220 indexed citations
11.
Preta, Giulio, Virginia Lotti, J. Cronin, & I. Martin Sheldon. (2014). Protective role of the dynamin inhibitor Dynasore against the cholesterol‐dependent cytolysin of Trueperella pyogenes. The FASEB Journal. 29(4). 1516–1528. 49 indexed citations
12.
Ceder, Rebecca, Giulio Preta, Katja Pokrovskaja Tamm, et al.. (2012). Requirement of Apoptotic Protease-Activating Factor-1 for Bortezomib-Induced Apoptosis but Not for Fas-Mediated Apoptosis in Human Leukemic Cells. Molecular Pharmacology. 83(1). 245–255. 9 indexed citations
13.
Preta, Giulio & Bengt Fadeel. (2012). AIF and Scythe (Bat3) Regulate Phosphatidylserine Exposure and Macrophage Clearance of Cells Undergoing Fas (APO-1)-Mediated Apoptosis. PLoS ONE. 7(10). e47328–e47328. 15 indexed citations
14.
Preta, Giulio & Bengt Fadeel. (2012). Scythe cleavage during Fas (APO‐1)‐and staurosporine‐mediated apoptosis. FEBS Letters. 586(6). 747–752. 12 indexed citations
16.
Preta, Giulio, et al.. (2010). MAP kinase-signaling controls nuclear translocation of tripeptidyl-peptidase II in response to DNA damage and oxidative stress. Biochemical and Biophysical Research Communications. 399(3). 324–330. 13 indexed citations
17.
Preta, Giulio, et al.. (2010). The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping and Stress. Journal of Oncology. 2010. 1–10. 11 indexed citations
18.
Preta, Giulio, et al.. (2009). A role for nuclear translocation of tripeptidyl-peptidase II in reactive oxygen species-dependent DNA damage responses. Biochemical and Biophysical Research Communications. 389(4). 575–579. 18 indexed citations
19.
Preta, Giulio, Diego Marescotti, Cinzia Fortini, et al.. (2008). Inhibition of Serine‐Peptidase Activity Enhances the Generation of a Survivin‐Derived HLA‐A2‐Presented CTL Epitope in Colon‐Carcinoma Cells. Scandinavian Journal of Immunology. 68(6). 579–588. 8 indexed citations
20.
Hoeflich, Andreas, Giulio Preta, Harald Lahm, et al.. (2003). Increased Activity of Catalase in Tumor Cells Overexpressing IGFBP-2. Hormone and Metabolic Research. 35(11/12). 816–821. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026